Episode 113: Sickle Cell Series - “Double Dut...

This week, we continue our Pancreatic Cancer series with the setting where most of our patients live: metastatic disease. Using our case of a patient with newly diagnosed metastatic pancreatic cancer, we trace how first-line chemotherapy evolved from single-agent gemcitabine to F ...  Show more

This week we continue our Pancreatic Cancer series with the two middle categories of non-metastatic disease: borderline resectable and locally advanced. Using the case of a 61-year-old woman with a pancreatic body mass abutting the superior mesenteric artery, we walk through the ...  Show more

This podcasts covers an approach to sickle cell including pathophysiology, diagnosis, history, physical exam, investigations and treatment.  It was developed by Noha Elsherbini a fourth year medical student at McGill University with Dr. Surabhi Rawal, a Pediatric Hematologist Onc ...  Show more

Sickle cell disease experts Drs. Angela Ellison [PEM] and Kim Smith-Whitley [Heme] join host Dr. Bob Belfer as they discuss advances in the care of children with this disease. 

Neglected and ignored by the medical establishment throughout most of its history, sickle cell disease remains one of the most common (and commonly misunderstood) genetic conditions in the world. In this episode, we break down the myriad effects that one nucleotide substitutio ...